Further Information
CD209, CD209 molecule, CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, C-type lectin domain family 4 member L, C-type lectin domain family 4, member L, CD209 antigen, HIV gpl20-binding protein, dendritic cell-specific ICAM-3-grabbing non-integrin 1, dendritic cell-spe
Peptide ELISA: antibody detection limit dilution 1:128000.Western Blot:Approx 50kDa band observed in Human Bone Marrow lysates (calculated MW of 45.8kDa according to NP_066978.1). The observed molecular weight corresponds to the glycosylated form. Recommended concentration: 0.1-0.3ug/ml.
- Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S.Role of DC-SIGN in Lassa virus entry into human dendritic cells.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-NRGEPNNVGEED
30835
CD209 molecule
CD209
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 50kDa
NP_066978.1, NP_001138368.1, NP_001138369.1, NP_001138365.1, NP_001138366.1, NP_001138367.1, NP_001138371.1
46396012
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Infectious Disease,HIV and HIV Related Infectious Disease Virus Related
This antibody is expected to recognize all reported isoforms.
Q9NNX6